Vyndaqel
Tafamidis meglumine · Pfizer Laboratories Div Pfizer Inc
PRESCRIPTION ONLY (USA)Vyndaqel ingredients
| Active ingredient | Strength |
|---|---|
| Tafamidis Meglumine | 20 mg/1 |
What Vyndaqel is used for
Vyndaqel is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Vyndaqel
- Generic name
- Tafamidis meglumine
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Capsule, Liquid Filled
- Given
- Oral
- FDA approval
- New drug application (NDA) NDA211996
- On the US market since
- 2019
Official information
- Vyndaqel prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Tafamidis meglumine)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vyndaqel?
Vyndaqel (Tafamidis meglumine) is a specialist medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Vyndaqel?
Vyndaqel contains Tafamidis Meglumine (20 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA